You are here

Chicago Biosolutions, Inc.

Company Information
Address
2242 West Harrison Suite 201
Chicago, IL 60612-3515
United States


N/A

Information

UEI: KJL4YQ7KSEK9

# of Employees: 4


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Development of 4-(aroylamino)piperidine-based entry inhibitors as anti-influenza therapeutics

    Amount: $999,369.00

    Influenza A viruses belong to the orthomyxoviridae family, and have a negative-sense, segmented RNA genome, which can cause seasonal or pandemic flu with high morbidity and significant mortality. Vacc ...

    STTRPhase II2022Department of Health and Human Services National Institutes of Health
  2. Development of 4-(aroylamino)piperidine-based entry inhibitors as anti-influenza therapeutics

    Amount: $300,000.00

    Influenza A viruses belong to the orthomyxoviridae family, and have a negative-sense, segmented RNA genome, which can cause seasonal or pandemic flu with high morbidity and significant mortality. Vacc ...

    STTRPhase I2021Department of Health and Human Services National Institutes of Health
  3. Furopyrimidines as novel inhibitors of henipaviruses

    Amount: $599,262.00

    The emergence and reemergence of pathogenic viruses represent continuous infectious disease threats to public health. Among these, the paramyxoviruses, which include many important human and animal pa ...

    STTRPhase I2021Department of Health and Human Services National Institutes of Health
  4. Development of group 2 influenza A virus entry inhibitors

    Amount: $599,998.00

    Influenza A viruses belong to the Orthomyxoviridae family with a negative-sense, segmented RNA genome, which can cause seasonal or pandemic flu with high morbidity and significant mortality. Vaccinati ...

    STTRPhase I2019Department of Health and Human Services National Institutes of Health
  5. 4-(Aminomethyl) benzamides as novel anti-Ebola agents

    Amount: $2,916,523.00

    Ebola (EBOV) and Marburg (MARV) viruses belong to the Filoviridae family and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction after an incubation period of 4-14 days. ...

    STTRPhase II2019Department of Health and Human Services National Institutes of Health
  6. Furopyrroles as Novel anti-Ebola Agents

    Amount: $225,000.00

    DESCRIPTION provided by applicant Ebola EBOV and Marburg MARV viruses belong to the family Filoviridae and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction with ...

    SBIRPhase I2016Department of Health and Human Services Centers for Disease Control and Prevention
  7. Aminopiperidines as novel anti influenza agents

    Amount: $396,096.00

    Influenza A viruses belong to the orthomyxoviridae family with a negative sense segmented RNA genome which can cause seasonal or pandemic flu with high morbidity and significant mortality Vaccinati ...

    STTRPhase I2016Department of Health and Human Services National Institutes of Health
  8. Aminomethyl benzamides as novel anti Ebola agents

    Amount: $727,199.00

    Ebola EBOV and Marburg MARV viruses belong to the family Filoviridae and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction with an incubation period of days B ...

    STTRPhase I2016Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government